BGLC NASDAQ
BioNexus Gene Lab Corp.
1W: -12.2%
1M: -17.0%
3M: -41.9%
YTD: -69.0%
1Y: -77.7%
3Y: -84.9%
$1.27
+0.07 (+5.83%)
Weekly Expected Move ±9.4%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Balance Sheet Trends
Total Assets
$10M
-8.5% ▼
5Y CAGR: +53.3%
Total Liabilities
$2M
+21.2% ▲
5Y CAGR: +80.9%
Shareholders Equity
$8M
-13.8% ▼
5Y CAGR: +49.3%
Cash & Investments
$4M
-26.2% ▼
5Y CAGR: +38.5%
Total Debt
$211K
+43.6% ▲
5Y CAGR: +18.7%
Net Debt
-$4M
+27.9% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $3M | $2M | $2M | $6M | $4M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $3M | $2M | $2M | $6M | $4M |
| Net Receivables | $4M | $3M | $3M | $857K | $2M |
| Inventory | $1M | $2M | $978K | $1M | $1M |
| Other Current Assets | $23K | $80K | $25K | $122K | $84K |
| Total Current Assets | $8M | $7M | $6M | $8M | $7M |
| Property, Plant & Equip. | $2M | $2M | $2M | $2M | $2M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $282K | $749K | $1M | $2M | $1M |
| Other Non-Current Assets | $0 | $68K | $0 | $0 | $0 |
| Total Non-Current Assets | $2M | $2M | $3M | $3M | $3M |
| Total Assets | $10M | $10M | $9M | $11M | $10M |
| — Liabilities — | |||||
| Accounts Payable | $3M | $2M | $2M | $1M | $2M |
| Short-Term Debt | $46K | $40K | $17K | $13K | $0 |
| Deferred Revenue | $0 | $108K | $23K | $0 | $96K |
| Other Current Liabilities | $96K | $72K | $103K | $181K | $301K |
| Total Current Liabilities | $3M | $2M | $2M | $2M | $2M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $12K | $0 |
| Total Non-Current Liabilities | $80K | $66K | $71K | $111K | $160K |
| Total Liabilities | $3M | $2M | $2M | $2M | $2M |
| — Equity — | |||||
| Common Stock | $11M | $11M | $11M | $17M | $17M |
| Retained Earnings | $761K | $2M | $1M | -$2M | -$3M |
| Accumulated OCI | $134K | -$100K | -$409K | -$677K | -$555K |
| Total Stockholders Equity | $7M | $7M | $7M | $10M | $8M |
| Total Liabilities & Equity | $10M | $10M | $9M | $11M | $10M |
| — Key Metrics — | |||||
| Total Debt | $123K | $77K | $57K | $147K | $211K |
| Net Debt | -$3M | -$2M | -$2M | -$6M | -$4M |
| Total Investments | $282K | $749K | $1M | $2M | $1M |